QUOTE AND NEWS
Business Wire  Nov 16  Comment 
Flamel Technologies (Nasdaq:FLML) today announced its financial results for the third quarter of 2009. Highlights in the third quarter included: Significant technical and preclinical success in moving forward with our existing projects. the signing
Business Wire  Nov 4  Comment 
Flamel Technologies (Nasdaq: FLML) expects to release its financial results for the third quarter of 2009 the morning of November 16th, before the market opening. A conference call to discuss the results has been scheduled for Monday, November 16th,
Business Wire  Nov 4  Comment 
Flamel Technologies (Nasdaq:FLML) today announced that Pfizer (NYSE:PFE) has exercised its option to license Flamel’s Medusa® technology for the development of a controlled release formulation of an already-marketed therapeutic protein. Flamel
Business Wire  Sep 18  Comment 
Flamel Technologies (Nasdaq:FLML) today announced that Stephen Willard, Flamel’s chief executive officer, will be presenting at the UBS Global Life Sciences Conference in New York. The presentation will take place at 10:00 AM on September 22nd. A
StreetInsider.com  Jul 13  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Baxter+%28BAX%29+and+Flamel+Technologies+%28FLML%29+Announce+Collaboration+to+Formulate+Longer+Acting+Forms+of+Blood+Clotting+Factors/4789270.html for the full story.
Stock Gumshoe  Jun 27  Comment 
This was part of a long and somewhat tiresome ad for Bottarelli Research Small Cap, which we've sleuthed out one or two teaser companies from before. This time, it was all about the way Bottarelli talked his friend Mark Blattert into publishing...
Suggest a News Source
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
Close 
Thanks for your suggestion!
 


 
FLML AT A GLANCE
 
 
 
 
 
 
 
 




References

Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki